Literature DB >> 34857948

How bad is Omicron? What scientists know so far.

Ewen Callaway, Heidi Ledford.   

Abstract

Entities:  

Keywords:  SARS-CoV-2; Vaccines; Virology

Mesh：

Substances：

Year:  2021        PMID： 34857948     DOI： 10.1038/d41586-021-03614-z

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   69.504


× No keyword cloud information.
  1 in total

1.  Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta.

Authors:  Lorenz Ulrich; Nico Joel Halwe; Adriano Taddeo; Nadine Ebert; Jacob Schön; Christelle Devisme; Bettina Salome Trüeb; Bernd Hoffmann; Manon Wider; Xiaoyu Fan; Meriem Bekliz; Manel Essaidi-Laziosi; Marie Luisa Schmidt; Daniela Niemeyer; Victor Max Corman; Anna Kraft; Aurélie Godel; Laura Laloli; Jenna N Kelly; Brenda M Calderon; Angele Breithaupt; Claudia Wylezich; Inês Berenguer Veiga; Mitra Gultom; Sarah Osman; Bin Zhou; Kenneth Adea; Benjamin Meyer; Christiane S Eberhardt; Lisa Thomann; Monika Gsell; Fabien Labroussaa; Jörg Jores; Artur Summerfield; Christian Drosten; Isabella Anne Eckerle; David E Wentworth; Ronald Dijkman; Donata Hoffmann; Volker Thiel; Martin Beer; Charaf Benarafa
Journal:  Nature       Date:  2021-12-22       Impact factor: 49.962
  1 in total
  85 in total

Review 1.  Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences.

Authors:  Reem Hoteit; Hadi M Yassine
Journal:  Vaccines (Basel)       Date:  2022-06-09

Review 2.  Pandemic COVID-19, an update of current status and new therapeutic strategies.

Authors:  Antonio Vitiello; Raffaele La Porta; Ugo Trama; Francesco Ferrara; Andrea Zovi; Amogh Milind Auti; Marina Di Domenico; Mariarosaria Boccellino
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-07-02       Impact factor: 3.195

3.  Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2.

Authors:  Ryuta Uraki; Maki Kiso; Shun Iida; Masaki Imai; Emi Takashita; Makoto Kuroda; Peter J Halfmann; Samantha Loeber; Tadashi Maemura; Seiya Yamayoshi; Seiichiro Fujisaki; Zhongde Wang; Mutsumi Ito; Michiko Ujie; Kiyoko Iwatsuki-Horimoto; Yuri Furusawa; Ryan Wright; Zhenlu Chong; Seiya Ozono; Atsuhiro Yasuhara; Hiroshi Ueki; Yuko Sakai-Tagawa; Rong Li; Yanan Liu; Deanna Larson; Michiko Koga; Takeya Tsutsumi; Eisuke Adachi; Makoto Saito; Shinya Yamamoto; Masao Hagihara; Keiko Mitamura; Tetsuro Sato; Masayuki Hojo; Shin-Ichiro Hattori; Kenji Maeda; Riccardo Valdez; Moe Okuda; Jurika Murakami; Calvin Duong; Sucheta Godbole; Daniel C Douek; Ken Maeda; Shinji Watanabe; Aubree Gordon; Norio Ohmagari; Hiroshi Yotsuyanagi; Michael S Diamond; Hideki Hasegawa; Hiroaki Mitsuya; Tadaki Suzuki; Yoshihiro Kawaoka
Journal:  Nature       Date:  2022-05-16       Impact factor: 69.504

4.  A Disproportionality Analysis for Association of Systemic Capillary Leak Syndrome with COVID-19 Vaccination Using the World Health Organization Pharmacovigilance Database.

Authors:  Jin Park; Dongyeop Kim; Tae-Jin Song
Journal:  Vaccines (Basel)       Date:  2022-05-25

5.  Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in children and adolescents in Delhi, India, from January to October 2021: a repeated cross-sectional analysis.

Authors:  Pragya Sharma; Saurav Basu; Suruchi Mishra; Mongjam Meghachandra Singh
Journal:  Osong Public Health Res Perspect       Date:  2022-06-10

Review 6.  Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.

Authors:  Cong Sun; Chu Xie; Guo-Long Bu; Lan-Yi Zhong; Mu-Sheng Zeng
Journal:  Signal Transduct Target Ther       Date:  2022-06-28

7.  A Calculator for COVID-19 Severity Prediction Based on Patient Risk Factors and Number of Vaccines Received.

Authors:  Ariel Israel; Alejandro A Schäffer; Eugene Merzon; Ilan Green; Eli Magen; Avivit Golan-Cohen; Shlomo Vinker; Eytan Ruppin
Journal:  Microorganisms       Date:  2022-06-16

Review 8.  Lessons from SARS‑CoV‑2 and its variants (Review).

Authors:  Ziwen Qin; Yan Sun; Jian Zhang; Ling Zhou; Yujuan Chen; Chuanjun Huang
Journal:  Mol Med Rep       Date:  2022-06-22       Impact factor: 3.423

Review 9.  Mutational Pattern, Impacts and Potential Preventive Strategies of Omicron SARS-CoV-2 Variant Infection.

Authors:  Endeshaw Chekol Abebe; Markeshaw Tiruneh G/Medhin; Awgichew Behaile T/Mariam; Tadesse Asmamaw Dejenie; Teklie Mengie Ayele; Fitalew Tadele Admasu; Zelalem Tilahun Muche; Getachew Asmare Adela
Journal:  Infect Drug Resist       Date:  2022-04-15       Impact factor: 4.177

10.  Response: Commentary: Pattern Recognition Proteins: First Line of Defense Against Coronaviruses.

Authors:  Carlos Alberto Labarrere; Ghassan S Kassab
Journal:  Front Immunol       Date:  2022-04-12       Impact factor: 8.786
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.